RSS-Feed abonnieren

DOI: 10.1055/s-0045-1809879
Ethical Challenges and Current Opportunities of Artificial Intelligence in Cardiology

Abstract
Artificial intelligence (AI) has great potential in diagnosing, managing, and predicting cardiovascular diseases through imaging, clinical decision support, remote monitoring, and optimizing treatment strategies. AI in cardiology brings unique ethical issues that need careful examination and resolution. There are several ethical concerns, including privacy, bias, trust, accountability, and responsibility. AI systems handle large quantities of data, which can present privacy and security risks if hacked or exploited illegally. AI models may exhibit biases due to limited or nonrepresentative training data sets, impacting their reliability. ChatGPT shows potential in cardiology for patient education, clinician support, and research facilitation. However, its use in direct patient care is limited due to concerns regarding accuracy, ethical issues, and the necessity for human oversight. AI's responsible development and application in cardiology hinges on thorough evaluation, regulatory compliance, and ethical oversight to ensure safety and effectiveness. The collaboration of health care professionals, data scientists, ethicists, researchers, and policymakers is essential for the advancement of AI in cardiology and the resolution of its associated challenges. Collaboration is mandatory to ensure AI tools improve patient care while upholding the highest medical standards. The incorporation of AI into cardiology offers significant potential for the coming years. With its extensive data sets and strong evidence-based guidelines, cardiology is ideally suited to using this technology.
Publikationsverlauf
Artikel online veröffentlicht:
20. Juni 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cerdas MG, Pandeti S, Reddy L. et al. The role of artificial intelligence and machine learning in cardiovascular imaging and diagnosis: current insights and future directions. Cureus 2024; 16 (10) e72311
- 2 Lewin S, Chetty R, Ihdayhid AR, Dwivedi G. Ethical challenges and opportunities in applying artificial intelligence to cardiovascular medicine. Can J Cardiol 2024; 40 (10) 1897-1906
- 3 Jain SS, Elias P, Poterucha T. et al. Artificial intelligence in cardiovascular care-part 2: applications: JACC review topic of the week. J Am Coll Cardiol 2024; 83 (24) 2487-2496
- 4 Avram R, Dwivedi G, Kaul P, Manlhiot C, Tsang W. Artificial intelligence in cardiovascular medicine: from clinical care, education, and research applications to foundational models-a perspective. Can J Cardiol 2024; 40 (10) 1769-1773
- 5 Murphy K, Di Ruggiero E, Upshur R. et al. Artificial intelligence for good health: a scoping review of the ethics literature. BMC Med Ethics 2021; 22 (01) 14
- 6 Lüscher TF, Wenzl FA, D'Ascenzo F, Friedman PA, Antoniades C. Artificial intelligence in cardiovascular medicine: clinical applications. Eur Heart J 2024; 45 (40) 4291-4304
- 7 Brown S. Heartificial intelligence: in what ways will artificial intelligence lead to changes in cardiology over the next 10 years. Br J Cardiol 2024; 31 (02) 015
- 8 Islam MS, Kalmady SV, Hindle A. et al. Diagnostic and prognostic models based on electrocardiograms for rapid clinical applications. Can J Cardiol 2024; 40 (10) 1788-1803
- 9 Doolub G, Khurshid S, Theriault-Lauzier P. et al. Revolutionizing acute cardiac care with artificial intelligence: opportunities and challenges. Can J Cardiol 2024; 40 (10) 1813-1827
- 10 Elias P, Jain SS, Poterucha T. et al. Artificial intelligence for cardiovascular care-part 1: advances: JACC review topic of the week. J Am Coll Cardiol 2024; 83 (24) 2472-2486
- 11 Crea F. Focus on amyloidosis, peripartum cardiomyopathy, and heart failure prediction by artificial intelligence applied to ECG. Eur Heart J 2025; 46 (11) 987-990
- 12 Sigfstead S, Jiang R, Avram R, Davies B, Krahn AD, Cheung CC. Applying artificial intelligence for phenotyping of inherited arrhythmia syndromes. Can J Cardiol 2024; 40 (10) 1841-1851
- 13 McLaren J, de Alencar JN, Aslanger EK, Meyers HP, Smith SW. From ST-segment elevation MI to occlusion MI: the new paradigm shift in acute myocardial infarction. JACC Adv 2024; 3 (11) 101314
- 14 Sahashi Y, Ouyang D, Okura H, Kagiyama N. AI-echocardiography: current status and future direction. J Cardiol 2025; x: x
- 15 Simonsen JØ, Modin D, Skaarup K. et al. Utilizing echocardiography and unsupervised machine learning for heart failure risk identification. Int J Cardiol 2025; 418: 132636
- 16 Nedadur R, Bhatt N, Liu T, Chu MWA, McCarthy PM, Kline A. The emerging and important role of artificial intelligence in cardiac surgery. Can J Cardiol 2024; 40 (10) 1865-1879
- 17 Tsai ML, Chen KF, Chen PC. Harnessing electronic health records and artificial intelligence for enhanced cardiovascular risk prediction: a comprehensive review. J Am Heart Assoc 2025; 14 (06) e036946
- 18 Tangsrivimol JA, Darzidehkalani E, Virk HUH. et al. Benefits, limits, and risks of ChatGPT in medicine. Front Artif Intell 2025; 8: 1518049
- 19 Ghanta SN, Al'Aref SJ, Lala-Trinidade A. et al. Applications of ChatGPT in heart failure prevention, diagnosis, management, and research: a narrative review. Diagnostics (Basel) 2024; 14 (21) 2393
- 20 Sharma A, Medapalli T, Alexandrou M, Brilakis E, Prasad A. Exploring the role of ChatGPT in cardiology: a systematic review of the current literature. Cureus 2024; 16 (04) e58936
- 21 Thorp HH. ChatGPT is fun, but not an author. Science 2023; 379 (6630) 313
- 22 Armoundas AA, Narayan SM, Arnett DK. et al; American Heart Association Institute for Precision Cardiovascular Medicine; Council on Cardiovascular and Stroke Nursing; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; and Stroke Council. Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association. Circulation 2024; 149 (14) e1028-e1050
- 23 Nolin-Lapalme A, Corbin D, Tastet O, Avram R, Hussin JG. Advancing fairness in cardiac care: strategies for mitigating bias in artificial intelligence models within cardiology. Can J Cardiol 2024; 40 (10) 1907-1921
- 24 Francisco A, Pascoal C, Lamborne P, Morais H, Gonçalves M. Wearables and atrial fibrillation: advances in detection, clinical impact, ethical concerns, and future perspectives. Cureus 2025; 17 (01) e77404
- 25 Rose SL, Shapiro D. An ethically supported framework for determining patient notification and informed consent practices when using artificial intelligence in health care. Chest 2024; 166 (03) 572-578
- 26 Marvasti TB, Gao Y, Murray KR, Hershman S, McIntosh C, Moayedi Y. Unlocking tomorrow's health care: expanding the clinical scope of wearables by applying artificial intelligence. Can J Cardiol 2024; 40 (10) 1934-1945
- 27 Bouhouita-Guermech S, Haidar H. Scoping review shows the dynamics and complexities inherent to the notion of “responsibility” in artificial intelligence within the healthcare context. Asian Bioeth Rev 2024; 16 (03) 315-344
- 28 Harishbhai Tilala M, Kumar Chenchala P, Choppadandi A. et al. Ethical considerations in the use of artificial intelligence and machine learning in health care: a comprehensive review. Cureus 2024; 16 (06) e62443